<<Back

THE CASSIE SHIPHERD GROUP PLACES VERONICA LUBATKIN ON PDI, INC. BOARD OF DIRECTORS.

PDI, Inc., a pioneer in providing contract sales and commercial services to the biopharmaceutical industry, announced the appointment of Veronica Lubatkin, CPA, 45, to the Company's board of directors. Ms. Lubatkin's appointment expands the number of board members to 11.

Ms. Lubatkin is Executive Vice President and Chief Financial Officer of Par Pharmaceutical Companies, Inc. and earlier served as Vice President, Controller. Prior to this, she was Executive Director, Strategic Partnerships of Schering-Plough Corporation, responsible for the worldwide controllership and alliance management activities of the Merck Schering-Plough Cholesterol Joint Venture. During this time, Ms. Lubatkin worked closely with senior management as well as sales, marketing and finance teams around the globe on the launches of Vytorin and Zetia. "We are delighted that Veronica has chosen to serve on our board of directors," commented John P. Dugan, PDI's chairman. "Her financial expertise and experience garnered in the finance organizations of top pharmaceutical companies will be invaluable as we reestablish our leadership in contract sales and support services to this industry."

Prior to joining Schering-Plough, Ms. Lubatkin was Finance Director for Neuman Distributors, Inc., formerly a $3 billion U.S. pharmaceutical wholesaler responsible for integration and due diligence processes. She began her career with Arthur Anderson in 1985.

Ms. Lubatkin earned a B.A. degree in Accounting from Pace University in 1985 and is a Certified Public Account.